SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000886163-14-000057
Filing Date
2014-05-22
Accepted
2014-05-22 16:01:41
Documents
3
Period of Report
2014-05-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ligand_8-kxcvrxamendmentsx.htm 8-K 35764
2 EXHIBIT 10.1 amendment_ofxgeneralxcvrxa.htm EX-10.1 34330
3 EXHIBIT 10.2 amendment_ofxtrxbetaxcvrxa.htm EX-10.2 32406
  Complete submission text file 0000886163-14-000057.txt   103654
Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 14863698
SIC: 2834 Pharmaceutical Preparations